Programme Titles Presenters
Sunday, 14 June 2015
12:00-14:00 Registration
Hall Tramuntana
14:00-14:15 Welcome and Introduction
Tramuntana 2&3
14:15-15:00 Keynote Sepaker | Lisa Coussens, Oregon Health & Science University, USA | Inflammation and cancer: Good cells behaving badly [KEY.01]
Tramuntana 2&3
15:00-15:30 Invited Speaker | Laurence Zitvogel, Institut Gustave Roussy, France | Impact of gut microbiota in the anticancer effects of ICB [INV.01]
Tramuntana 2&3
15:30-16:00 Refreshment break - Sponsored by Seahorse Bioscience
Tramuntana 1
16:00-16:30 Invited Speaker | Giorgio Trinchieri, National Institutes of Health, USA | Cancer as a disease of the symbiont/metaorganism [INV.02]
Tramuntana 1
16:30-17:00 Invited Speaker | Alberto Mantovani, University of Milan, Italy | Tumor associated macrophages in tumor progression: From bench to bedside [INV.03]
Tramuntana 2&3
17:00-17:15 Short Talk | Marta Brandt, Centro National de Investigaciones Oncologicas, Spain | MCRS1 protects from inflammation-induced colon cancer [ST.01]
Tramuntana 2&3
17:15-18:30 Welcome drinks reception
Tramuntana 1
Monday, 15 June 2015
08:00-09:00 Continental Breakfast - Sponsored by NanoString
Tramuntana 1
NanoString Workshop - Biomarker development for Cancer Immuno-Oncology/Immuno-Therapy: Simultaneous Digital Counting of Nucleic-Acids and Proteins at 800-plex
Tramuntana 2 & 3
09:00-09:30 Invited Speaker | Fiona Powrie, University of Oxford, UK | Inflammation driven cancer: Host and microbial pathways [INV.04]
Tramuntana 2&3
09:30-10:00 Invited Speaker | Michael Karin, University of California San Diego, USA | Nurture and nature: Signaling cascades controlled by inflammatory cytokines are critical for the progression of genetically determined colorectal cancer [INV.05]
Tramuntana 2&3
10:00-10:15 Short Talk | Sergei Grivennikov, Fox Chase Cancer Center, USA | Molecular and cellular mechanisms of tumor-elicited inflammation in colorectal cancer [ST.02]
Tramuntana 2&3
10:15-10:30 Short Talk | Donnele Daley, NYU School of Medicine, USA | T cells are the primary lymphocyte subset in pancreatic carcinoma and support oncogenesis by inducing T cell exhaustion [ST.03]
Tramuntana 2&3
10:30-11:00 Refreshment break
Tramuntana 1
11:00-11:30 Invited Speaker | Johanna Joyce, Memorial Sloan Kettering Cancer Center, USA | Deciphering mechanisms of resistance to microenvironment-targeted therapies [INV.06]
Tramuntana 2&3
11:30-12:00 Invited Speaker | Jerome Galon, Cordeliers Research Center; INSERM, France | Immune landscape and Immunoscore in the era of cancer immunotherapies [INV.07]
Tramuntana 2&3
12:00-12:45 Meet the editors
Tramuntana 2&3
12:45-13:45 Lunch - Sponsored by ThermoFisher Scientific
Restaurant
13:45-14:45 Poster session 1
Tramuntana 1
14:45-15:15 Invited Speaker | Jeffrey Pollard, University of Edinburgh, UK | Macrophages: Immunosuppressive cells that promote tumor progression and metastasis [INV.08]
Tramuntana 2&3
15:15-15:45 Invited Speaker | Rafi Ahmed, Emory Vaccine Center, USA | Title – TBC [INV.13]
Tramuntana 2&3
15:45-16:00 Short Talk | Andreas Weigert, Goethe-University, Germany | Sphingosine-1-phosphate receptor 1 on tumor-associated macrophages promotes Nlrp3/IL-1beta-dependent lymphangiogenesis and metastasis [ST.04]
Tramuntana 2&3
16:00-16:30 Refreshment break
Tramuntana 1
16:30-17:00 Invited Speaker | Peter Murray, St Jude Children's Research Hospital, USA | Genetic dissection of macrophage polarization in cancer [INV.10]
Tramuntana 2&3
17:00-17:30 Invited Speaker | Carola Ries, Roche Pharmaceuticals, Germany | Targeting tumor-associated macrophages in mice and men [INV.11]
Tramuntana 2&3
17:30-17:45 Short Talk | Santiago Zelenay, CRUK London Research Institute, UK | Cyclooxygenase-dependent melanoma growth through evasion of innate and adaptive immunity [ST.05]
Tramuntana 2&3
17:45-18:00 Short Talk | Matthew Lakins. University of Cambridge, UK | Cancer-associated fibroblasts protect tumour cells via antigen-specific deletion of CD8+ cytotoxic T cells [ST.06]
Tramuntana 2&3
19:00-22:30 Meet the speakers dinner – ticket holders only - Sponsored by ThermoFisher Scientific
Can Laury Restaurant
Tuesday, 16 June 2015
08:00-09:00 Continental Breakfast - Sponsored by NanoString
Tramuntana 1
09:00-09:30 Invited Speaker | Alexander Rudensky, Memorial Sloan Kettering Cancer Center, USA | Title – TBC [INV.12]
Tramuntana 2&3
09:30-10:00 Invited Speaker | Vincenzo Bronte, University of Verona, Italy | Adoptive cell therapy reprograms tumor-infiltrating myelomonocytic cells [INV.09]
Tramuntana 2&3
10:00-10:15 Short Talk | Guy Shakhar, Weizmann Institute, Israel | Intravital imaging of melanoma reveals that target cytolysis by CTLs is strictly contact and antigen-dependent [ST.07]
Tramuntana 2&3
10:15-10:30 Short Talk | Weiyi Peng, MD Anderson Cancer Center, USA | PTEN loss in melanoma promotes resistance to T-cell-mediated antitumor immune responses [ST.08]
Tramuntana 2&3
10:30-11:00 Refreshment break
Tramuntana 1
11:00-11:30 Invited Speaker | Padmanee Sharma, MD Anderson Cancer Center, USA | From the clinic to the lab: Investigating immune responses to immune checkpoint therapies [INV.14]
Tramuntana 2&3
11:30-12:00 Invited Speaker | Ignacio Melero, University of Navarra, Spain | CD137 (4-1BB): New mechanisms and efficacious immunotherapies [INV.15]
Tramuntana 2&3
12:00-12:30 Invited Speaker | Michel Sadelain, Memorial Sloan Kettering Cancer Center, USA | CAR therapy and the promise of T cell engineering [INV.16]
Tramuntana 2&3
12:30-12:45 Short Talk | Mahesh Yadav, Genentech, USA | Targeting tumor specific mutations in cancer immunotherapy [ST.09]
Tramuntana 2&3
12:45-13:45 Lunch - Sponsored by ThermoFisher Scientific
Restaurant
13:45-14:45 Poster Session 2
Tramuntana 1
14:45-15:30 Short Talk | AJ Minn, University of Pennsylvania, USA | Non-Redundant Immune Effector Mechanisms Activated by Radiation and Dual PD-L1 and CTLA4 Blockade [ST.10]
Tramuntana 2&3
15:00-15:30 Invited Speaker | George Coukos, Ludwig Center for Cancer Research of the University of Lausanne, Switzerland | Mechanisms regulating T cell homing in tumors [INV.17]
Tramuntana 2&3
15:30-16:00 Refreshment break
Tramuntana 1
16:00-16:30 Invited Speaker | Ira Mellman, Genentech, USA | The mechanistic basis of cancer immunotherapy [INV.18]
Tramuntana 2&3
16:30-17:15 Keynote Speaker | James Allison, University of Texas MD Anderson Cancer Center, USA | Title – TBC [KEY.02]
Tramuntana 2&3
17:15-17:30 Closing remarks
Tramuntana 2&3
Copyright 2016 Elsevier Limited. Privacy | Terms | Cookies
Powered by Oxford Abstracts. Cookies are set by this site. To decline them or learn more, visit our Cookies page.